Join
Live feed
·
NEWSReleasevia Quantisnow
YS Biopharma Co. Ltd. logo

YS Biopharma Receives 180 Day Extension By Nasdaq To Regain Compliance With Minimum Bid Price Rule

ByQuantisnow·Wall Street's wire, on your screen.
YS· YS Biopharma Co. Ltd.
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track YS (YS Biopharma Co. Ltd.) and more on Quantisnow.